TOPOISOMERASE-TARGETING ANTITUMOR DRUGS

[1] CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) : 5565 - 5569

[2] CAMPTOTHECIN, A SPECIFIC INHIBITOR OF TYPE-I DNA TOPOISOMERASE, INDUCES DNA BREAKAGE AT REPLICATION FORKS [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (08) : 3026 - 3034

[3] ILLEGITIMATE RECOMBINATION MEDIATED BY CALF THYMUS DNA TOPOISOMERASE-II INVITRO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) : 2076 - 2080

[4] BARLOGIE B, 1976, CANCER RES, V36, P1975

[5] CELL-CYCLE STAGE-DEPENDENT INDUCTION OF G2 PHASE ARREST BY DIFFERENT ANTI-TUMOR AGENTS [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (07) : 741 - 745

[6] TOPOISOMERASES AS NOVEL TARGETS FOR CANCER-CHEMOTHERAPY [J]. BIO-TECHNOLOGY, 1988, 6 (11): : 1315 - 1319

[7] BODLEY AL, 1989, IN PRESS CANCER RES

[8] INHIBITION OF TYPE-II TOPOISOMERASE BY FOSTRIECIN [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (21) : 4063 - 4068

[9] NEED FOR DNA TOPOISOMERASE ACTIVITY AS A SWIVEL FOR DNA-REPLICATION FOR TRANSCRIPTION OF RIBOSOMAL-RNA [J]. NATURE, 1987, 326 (6111) : 414 - 416

[10] ATP INHIBITS NUCLEAR AND MITOCHONDRIAL TYPE-I TOPOISOMERASES FROM HUMAN-LEUKEMIA CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) : 1680 - 1684

[1] CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) : 5565 - 5569

[2] CAMPTOTHECIN, A SPECIFIC INHIBITOR OF TYPE-I DNA TOPOISOMERASE, INDUCES DNA BREAKAGE AT REPLICATION FORKS [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (08) : 3026 - 3034

[3] ILLEGITIMATE RECOMBINATION MEDIATED BY CALF THYMUS DNA TOPOISOMERASE-II INVITRO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) : 2076 - 2080

[4] BARLOGIE B, 1976, CANCER RES, V36, P1975

[5] CELL-CYCLE STAGE-DEPENDENT INDUCTION OF G2 PHASE ARREST BY DIFFERENT ANTI-TUMOR AGENTS [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (07) : 741 - 745

[6] TOPOISOMERASES AS NOVEL TARGETS FOR CANCER-CHEMOTHERAPY [J]. BIO-TECHNOLOGY, 1988, 6 (11): : 1315 - 1319

[7] BODLEY AL, 1989, IN PRESS CANCER RES

[8] INHIBITION OF TYPE-II TOPOISOMERASE BY FOSTRIECIN [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (21) : 4063 - 4068

[9] NEED FOR DNA TOPOISOMERASE ACTIVITY AS A SWIVEL FOR DNA-REPLICATION FOR TRANSCRIPTION OF RIBOSOMAL-RNA [J]. NATURE, 1987, 326 (6111) : 414 - 416

[10] ATP INHIBITS NUCLEAR AND MITOCHONDRIAL TYPE-I TOPOISOMERASES FROM HUMAN-LEUKEMIA CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) : 1680 - 1684